Published in Arch Pathol Lab Med on February 01, 2010
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol (2010) 3.32
Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell (2011) 3.00
Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infect Control Hosp Epidemiol (2010) 2.29
Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis (2013) 2.29
Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J Infect Dis (2010) 2.03
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax (2011) 1.91
Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care (2010) 1.83
Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog (2010) 1.70
Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proc Natl Acad Sci U S A (2011) 1.67
Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine (2011) 1.59
Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS One (2010) 1.56
Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol (2010) 1.55
Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol (2010) 1.47
Pandemic influenza: certain uncertainties. Rev Med Virol (2011) 1.39
pH1N1 influenza A: timing is everything. Crit Care Med (2010) 1.38
Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. MBio (2011) 1.36
Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Transl Med (2013) 1.35
Pulmonary sequelae in a patient recovered from swine flu. Lung India (2012) 1.32
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. Virology (2011) 1.25
IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol (2012) 1.22
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease. Infect Immun (2015) 1.17
Follow-up aspects of influenza A (H1N1) virus-associated pneumonia: the role of high-resolution computed tomography in the evaluation of the recovery phase. Korean J Radiol (2010) 1.17
Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection. Br J Radiol (2011) 1.16
Impaired wound healing predisposes obese mice to severe influenza virus infection. J Infect Dis (2011) 1.12
Comparison of pandemic (H1N1) 2009 and seasonal influenza viral loads, Singapore. Emerg Infect Dis (2011) 1.12
Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. J Infect Dis (2010) 1.11
Innate immune response of human alveolar macrophages during influenza A infection. PLoS One (2012) 1.10
Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. Mayo Clin Proc (2010) 1.10
Immune dysfunction and bacterial coinfections following influenza. J Immunol (2013) 1.10
Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med (2010) 1.09
High-throughput RNA sequencing of a formalin-fixed, paraffin-embedded autopsy lung tissue sample from the 1918 influenza pandemic. J Pathol (2013) 1.09
Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol (2010) 1.09
Obesity and respiratory infections: does excess adiposity weigh down host defense? Pulm Pharmacol Ther (2012) 1.08
Comparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts. J Virol (2011) 1.05
The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol (2015) 1.02
Insights on influenza pathogenesis from the grave. Virus Res (2011) 1.01
Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria. PLoS One (2012) 1.00
Organising pneumonia as a late abnormality in influenza A (H1N1) virus infection. Br J Radiol (2012) 0.99
Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. J Infect Dis (2011) 0.99
Influenza A (H1N1) 2009: Impact on Frankfurt in due consideration of health care and public health. J Occup Med Toxicol (2010) 0.97
Organizing pneumonia as a pulmonary sequela of swine flu. Lung India (2013) 0.96
Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation. J Virol (2012) 0.96
Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia. Antimicrob Agents Chemother (2011) 0.92
Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus. Influenza Other Respir Viruses (2011) 0.92
Diagnosis of influenza from respiratory autopsy tissues: detection of virus by real-time reverse transcription-PCR in 222 cases. J Mol Diagn (2011) 0.91
An assessment of H1N1 influenza-associated acute respiratory distress syndrome severity after adjustment for treatment characteristics. PLoS One (2011) 0.90
Soluble, but not transmembrane, TNF-α is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathology. J Immunol (2014) 0.90
Pathological and ultrastructural analysis of surgical lung biopsies in patients with swine-origin influenza type A/H1N1 and acute respiratory failure. Clinics (Sao Paulo) (2010) 0.89
The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol (2015) 0.89
Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates. Vaccine (2012) 0.88
Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses. Semin Immunol (2012) 0.88
Influenza and bacterial pathogen coinfections in the 20th century. Interdiscip Perspect Infect Dis (2011) 0.88
Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice. PLoS One (2013) 0.88
C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis (2010) 0.87
Molecular imaging reveals a progressive pulmonary inflammation in lower airways in ferrets infected with 2009 H1N1 pandemic influenza virus. PLoS One (2012) 0.87
mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection. Virology (2014) 0.87
Validation of normal human bronchial epithelial cells as a model for influenza A infections in human distal trachea. J Histochem Cytochem (2015) 0.86
Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity. Thorax (2011) 0.86
Mesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenza. PLoS One (2013) 0.85
The role of radiology in influenza: novel H1N1 and lessons learned from the 1918 pandemic. J Am Coll Radiol (2010) 0.85
Influenza-induced innate immunity: regulators of viral replication, respiratory tract pathology & adaptive immunity. Future Virol (2011) 0.85
Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice. J Virol (2011) 0.84
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis (2011) 0.84
Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response. J Immunol (2014) 0.83
Impaired clearance of influenza A virus in obese, leptin receptor deficient mice is independent of leptin signaling in the lung epithelium and macrophages. PLoS One (2014) 0.83
Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic. BMC Infect Dis (2010) 0.83
Viral-bacterial interactions-therapeutic implications. Influenza Other Respir Viruses (2013) 0.83
Dietary abscisic acid ameliorates influenza-virus-associated disease and pulmonary immunopathology through a PPARγ-dependent mechanism. J Nutr Biochem (2012) 0.82
Terminal sialic acids are an important determinant of pulmonary endothelial barrier integrity. Am J Physiol Lung Cell Mol Physiol (2012) 0.82
Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study. PLoS One (2012) 0.82
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. PLoS One (2012) 0.82
Pulmonary pathology of pandemic influenza A/H1N1 virus (2009)-infected ferrets upon longitudinal evaluation by computed tomography. J Gen Virol (2011) 0.82
Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung. Vet Res (2014) 0.82
Rapid sequencing of influenza A virus vRNA, cRNA and mRNA non-coding regions. J Virol Methods (2013) 0.80
Molecular imaging of influenza and other emerging respiratory viral infections. J Infect Dis (2011) 0.80
Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection. J Gen Virol (2014) 0.80
Influenza A/H1N1 Severe Pneumonia: Novel Morphocytological Findings in Bronchoalveolar Lavage. Interdiscip Perspect Infect Dis (2014) 0.80
Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship. Crit Care (2015) 0.79
Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza Viruses. J Virol (2015) 0.79
A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection. J Virol (2014) 0.78
Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis? World J Biol Chem (2010) 0.78
Influenza pathogenicity during pregnancy in women and animal models. Semin Immunopathol (2016) 0.78
Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States. BMC Infect Dis (2013) 0.77
Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils. J Virol (2015) 0.76
The application of bi-level positive airway pressure in patients with severe pneumonia and acute respiratory failure caused by influenza A (H1N1) virus. J Thorac Dis (2010) 0.76
A case of asymptomatic, localized, and idiopathic diffuse alveolar damage. Tuberc Respir Dis (Seoul) (2012) 0.75
Influenza and respiratory syncytial virus are the major respiratory viruses detected from prospective testing of pediatric and adult coronial autopsies. Influenza Other Respir Viruses (2013) 0.75
1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans. J Pathol (2015) 0.75
Recurrent Spontaneous Pneumothorax during the Recovery Phase of ARDS Due to H1N1 Infection. Balkan Med J (2013) 0.75
Successful treatment of suspected organizing pneumonia in a patient with Middle East respiratory syndrome coronavirus infection: a case report. J Thorac Dis (2016) 0.75
Swine flu fibrosis: Regressive or progressive? Lung India (2016) 0.75
The health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) during an annual influenza epidemic and influenza pandemic in China. BMC Infect Dis (2015) 0.75
Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response. PLoS One (2015) 0.75
Quantitative detection of Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae in patients with new influenza A (H1N1)/2009 and influenza A/2010 virus infection. GMS Hyg Infect Control (2015) 0.75
Authors' reply. Lung India (2013) 0.75
The 2009 H1N1 pandemic adds to our knowledge of influenza pathogenesis. Am J Pathol (2010) 0.75
Postviral Complications: Bacterial Pneumonia. Clin Chest Med (2016) 0.75
Secondary Bacterial Infections Associated with Influenza Pandemics. Front Microbiol (2017) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21
1918 Influenza: the mother of all pandemics. Emerg Infect Dis (2006) 12.11
Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med (2002) 11.85
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis (2008) 11.01
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep (2009) 9.94
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis (1998) 8.51
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep (2009) 6.08
The pathology of influenza virus infections. Annu Rev Pathol (2008) 5.37
Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep (2009) 5.25
Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill (2009) 5.18
Obesity. N Engl J Med (2002) 4.29
Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill (2009) 4.23
The persistent legacy of the 1918 influenza virus. N Engl J Med (2009) 3.58
2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep (2009) 3.35
Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol (2007) 3.04
Pathology of human influenza revisited. Vaccine (2008) 2.71
Optimization of the Isolation and Amplification of RNA From Formalin-fixed, Paraffin-embedded Tissue: The Armed Forces Institute of Pathology Experience and Literature Review. Mol Diagn (1997) 2.70
Using RRT-PCR analysis and virus isolation to determine the prevalence of avian influenza virus infections in ducks at Minto Flats State Game Refuge, Alaska, during August 2005. Arch Virol (2007) 2.28
Pandemic influenza--including a risk assessment of H5N1. Rev Sci Tech (2009) 2.27
Detection of novel (swine origin) H1N1 influenza A virus by quantitative real-time reverse transcription-PCR. J Clin Microbiol (2009) 1.93
Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust (2009) 1.81
Pneumococcal pneumonia and influenza: a deadly combination. Vaccine (2009) 1.78
Evaluation of PCR testing of ethanol-fixed nasal swab specimens as an augmented surveillance strategy for influenza virus and adenovirus identification. J Clin Microbiol (2005) 1.76
Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis (2006) 1.69
Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol (2009) 1.53
Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. Am J Clin Pathol (2000) 1.22
Pulmonary and cardiovascular complications of obesity: an autopsy study of 76 obese subjects. Arch Pathol Lab Med (2008) 1.09
Planning for an influenza pandemic: thinking beyond the virus. J Infect Dis (2008) 1.01
Usefulness of immunohistochemical diagnosis of streptococcus pneumoniae in formalin-fixed, paraffin-embedded specimens compared with culture and gram stain techniques. Am J Clin Pathol (2007) 0.98
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
1918 Influenza: the mother of all pandemics. Emerg Infect Dis (2006) 12.11
Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature (2005) 11.99
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis (2008) 11.01
The genomic and epidemiological dynamics of human influenza A virus. Nature (2008) 10.26
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology (2012) 6.92
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol (2007) 5.79
Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol (2005) 5.48
The pathology of influenza virus infections. Annu Rev Pathol (2008) 5.37
The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst (2012) 5.27
The 2004 World Health Organization classification of lung tumors. Semin Roentgenol (2005) 5.23
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest (2007) 5.17
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg (2012) 4.68
Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev (2008) 4.46
Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A (2002) 4.26
The evolutionary genetics and emergence of avian influenza viruses in wild birds. PLoS Pathog (2008) 4.17
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2004) 4.00
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol (2011) 3.92
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
Zika Virus in the Americas--Yet Another Arbovirus Threat. N Engl J Med (2016) 3.78
The perpetual challenge of infectious diseases. N Engl J Med (2012) 3.77
Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med (2007) 3.72
Effective post-exposure treatment of Ebola infection. PLoS Pathog (2007) 3.69
The persistent legacy of the 1918 influenza virus. N Engl J Med (2009) 3.58
Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res (2004) 3.43
Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. Am J Respir Crit Care Med (2012) 3.42
Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol (2008) 3.30
Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog (2008) 3.25
Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat Rev Microbiol (2004) 3.19
Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med (2005) 3.19
Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med (2008) 3.04
The origin of the 1918 pandemic influenza virus: a continuing enigma. J Gen Virol (2003) 2.98
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med (2004) 2.97
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol (2015) 2.95
Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations. Clin Cancer Res (2012) 2.85
Pathology of human influenza revisited. Vaccine (2008) 2.71
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2003) 2.71
Solid cancers after allogeneic hematopoietic cell transplantation. Blood (2008) 2.56
Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J Virol (2004) 2.55
Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis (2011) 2.52
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med (2012) 2.46
US lung cancer trends by histologic type. Cancer (2014) 2.46
Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. J Natl Cancer Inst (2013) 2.45
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol (2012) 2.45
Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med (2006) 2.37
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med (2003) 2.35
Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antivir Ther (2007) 2.32
1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. Emerg Infect Dis (2003) 2.32
Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res (2003) 2.31
Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis (2004) 2.25
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol (2011) 2.24
Pause on avian flu transmission research. Science (2012) 2.24
Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol (2013) 2.22
Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol (2002) 2.21
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2002) 2.21
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 2.20
Ebola hemorrhagic fever and septic shock. J Infect Dis (2003) 2.19
A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol (2010) 2.15
Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med (2002) 2.11
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2003) 2.10
Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol (2003) 2.08
Characterization of the 1918 "Spanish" influenza virus matrix gene segment. J Virol (2002) 2.05
Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study. J Thorac Oncol (2014) 2.04
Prognostic immune markers in non-small cell lung cancer. Clin Cancer Res (2011) 2.03
Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J Infect Dis (2010) 2.03
Pandemic influenza: an inconvenient mutation. Science (2009) 2.00
Lung cancer screening. J Natl Compr Canc Netw (2012) 2.00
Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky. J Infect Dis (2012) 1.95
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med (2007) 1.94
Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res (2013) 1.93
Detection of novel (swine origin) H1N1 influenza A virus by quantitative real-time reverse transcription-PCR. J Clin Microbiol (2009) 1.93
Early interstitial lung disease in familial pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.91
Is pneumonectomy mandatory after transection of the left main pulmonary artery? J Thorac Cardiovasc Surg (2009) 1.91
Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis (2010) 1.89
The next influenza pandemic: can it be predicted? JAMA (2007) 1.86
Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res (2008) 1.86
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med (2009) 1.85
Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer (2003) 1.85
Localized malignant mesothelioma. Am J Surg Pathol (2005) 1.83
Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J Virol (2009) 1.79
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J Cell Mol Med (2009) 1.79